8-K current report · filed Jul 15, 2026

Cytek Biosciences, Inc. (CTKB) 8-K Current Report: July 15, 2026

Item 5.02CTKB overview

Short answer

Cytek Biosciences, Inc. (CTKB) filed an 8-K current report with the SEC on July 15, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers). Former Chief Legal Officer Valerie Barnett received $365,775.12 lump-sum severance after her June 29 termination.

Cytek Biosciences, Inc. 8-K event analysis

AI summary of each reported item and its exhibits

Item 5.02 · Departure/Election of Directors or Officers

  • Former Chief Legal Officer Valerie Barnett received $365,775.12 lump-sum severance after her June 29 termination
  • COBRA coverage continues through April 30, 2027, subject to earlier coverage under another employer plan
  • Change in control within three months could trigger 18 months’ salary plus her 2026 bonus target
  • Transition consulting runs through August 31, 2026 at $1,000 hourly, capped at 10 hours weekly
  • Outstanding equity awards continue vesting during consulting, subject to continuous service and award terms

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Cytek Biosciences, Inc. 8-K filings

Get the next CTKB 8-K as it lands

Follow CTKB for push alerts, or ask the research agent what this filing means.